The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome
Abstract
Cushing’s syndrome is commonly complicated with an impairment of glucose metabolism, which is often clinically manifested as diabetes mellitus. The development of diabetes mellitus in Cushing’s syndrome is both a direct and indirect consequence of glucocorticoid excess. Indeed, glucocorticoid excess induces a stimulation of gluconeogenesis in the liver as well as an inhibition of insulin sensitivity both in the liver and in the skeletal muscles, which represent the most important sites responsible for glucose metabolism. In particular, glucocorticoid excess stimulates the expression of several key enzymes involved in the process of gluconeogenesis, with a consequent increase of glucose production, and induces an impairment of insulin sensitivity either directly by interfering with the insulin receptor signaling pathway or indirectly, through the stimulation of lipolysis and proteolysis and the consequent increase of fatty acids and amino acids, which contribute to the development of insulin resistance. Moreover, the peculiar distribution of adipose tissue throughout the body, with the predominance of visceral adipose tissue, significantly contributes to the worsening of insulin resistance and the development of a metabolic syndrome, which participates in the occurrence and maintenance of the impairment of glucose tolerance. Finally, glucocorticoid excess is able to impair insulin secretion as well as act at the level of the pancreatic beta cells, where it inhibits different steps of the insulin secretion process. This phenomenon is probably responsible for the passage from an impairment of glucose tolerance to an overt diabetes mellitus in susceptible patients with Cushing’s syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is the case in both endogenous and medication-induced hypercortisolism (Cushing's syndrome), with up to 70% of patients developing impaired glycaemic control ( 4 ).”
From Dynamic modulation of glucose utilisation by glucocorticoid rhythms in health and disease (2020) · cites this paper as [4]
In the citing paper
“with chronic CORT excess (hypercortisolism) commonly associated with the impairment of glucose metabolism and the development of secondary type 2 diabetes ( 3, 4 ).”
From Dynamic modulation of glucose utilisation by glucocorticoid rhythms in health and disease (2020) · cites this paper as [4]
In the citing paper
“and by stimulating liver gluconeogenesis and glycogenolysis ( 4, 15 ).”
From Dynamic modulation of glucose utilisation by glucocorticoid rhythms in health and disease (2020) · cites this paper as [4]
Citations
Cites
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731
RIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696 · cited 1×
“This action mainly reflects on a decrease of glycogen synthesis and glucose uptake. The direct interference of GCs with the insulin receptor signaling pathway has been demonstrated mostly in animal by in vitro and in vivo studies, which confirmed that GCs do not influence insulin receptor expression but mainly induce…”
BackgroundGlucocorticoids, metabolism and metabolic diseases
Vegiopoulos, A., & Herzig, S. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.015 · Cited by 535
Van Raalte, D. H., Ouwens, D. M., & Diamant, M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02067.x · Cited by 439
Effects of glucocorticoids on carbohydrate metabolism
Mcmahon, M., Gerich, J., & Rizza, R. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040105 · Cited by 390
Saad, M. J., Folli, F., Kahn, J. A., & Kahn, C. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116803 · Cited by 349
Hormonal regulation of hepatic gluconeogenesis.
Kraus-Friedmann, N. (1984) · Physiological Reviews · doi:10.1152/physrev.1984.64.1.170 · Cited by 276
Ruzzin, J., Wagman, A. S., & Jensen, J. (2005) · Diabetologia · doi:10.1007/s00125-005-1886-0 · Cited by 243
Flagged first, then by citations
Research works printed but not linked: 5
- 10.1042%2FCS19980388 · DOI
- 10.1210%2Fjc.77.5.1180 · DOI · Paper page
- 10.1007%2Fs00125-003-1190-9 · DOI · Paper page
- 10.1074%2Fjbc.272.48.30261 · DOI
- 10.1210%2Fjc.81.7.2621 · DOI
Cited by
Sorted by citations
Items 101–188 of 188
Fano, M. D., Falorni, A., Malara, M., Porcellati, F., & Fanelli, C. G. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s466328 · Cited by 11
Miceli, D. D., Blatter, M. F. C., Gallelli, M. F., Pignataro, O. P., & Castillo, V. A. (2014) · Research in Veterinary Science · doi:10.1016/j.rvsc.2014.07.014 · Cited by 11
Han, M., Cao, X., Zhao, C., Yang, L., Yin, N., Shen, P., Zhang, J., Gao, F., Ren, Y., Liang, D., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.544752 · Cited by 10
Kalra, S., Lakhani, O., & CHAUDHARY, S. K. (2020) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2020.16.2.97 · Cited by 10
Gan, L., Li, N., Heizhati, M., Li, M., Yao, L., Hong, J., Wu, T., Wang, H., Liu, M., & Maitituersun, A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad184 · Cited by 10
DeFronzo, R. A., Auchus, R. J., Bancos, I., Blonde, L., Busch, R. S., Buse, J. B., Findling, J. W., Fonseca, V. A., Frías, J. P., Hamidi, O., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081121 · Cited by 11
Kumar, N., Jarial, K., Bhansali, A., Nehra, R., Vyas, S., & Walia, R. (2020) · Indian journal of endocrinology and metabolism · doi:10.4103/ijem.ijem_162_20 · Cited by 4
Dynamic modulation of glucose utilisation by glucocorticoid rhythms in health and disease
Zavala, E., Gil-Gómez, C. A., Wedgwood, K. C. A., Burgess, R., Tsaneva-Atanasova, K., & Herrera-Valdez, M. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.27.968354 · Cited by 8
Effets indésirables métaboliques et cardiovasculaires des corticothérapies systémiques
Fardet, L. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.12.005 · Cited by 8
Sindelar, D. K., Carson, M. W., Morin, M., Shaw, J., Barr, R. J., Need, A. B., Alexander-Chacko, J. T., Coghlan, M. J., & Gehlert, D. R. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.205864 · Cited by 7
Jurczynski, K., Gruber-Dujardin, E., Widmer, D., Kaup, F. ‐., & Mätz‐Rensing, K. (2012) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2012.00538.x · Cited by 7
Chihaoui, M., Oueslati, I., Khessairi, N., Chaker, F., Cherni, S., Hammami, B., Feki, M., & Yazidi, M. (2023) · Endocrine Regulations · doi:10.2478/enr-2023-0017 · Cited by 6
Primary and secondary insulin resistance
Mokáň, M., & Galajda, P. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.045 · Cited by 6
Steroid as double edged sword; a catastrophic event in the rural part of Nepal
Neupane, S. K., Jaishi, P. P., Koirala, D., & Neupane, P. K. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104697 · Cited by 6
Kim, H., Kang, J., Jung, D., Kang, B., Chang, D., & Yang, M. (2020) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2020.106506 · Cited by 5
Chhatrola, S., Viroja, D., & Kyada, A. (2024) · IP International Journal of Comprehensive and Advanced Pharmacology · doi:10.18231/j.ijcaap.2024.005 · Cited by 9
Shirif, A. Z., Kovačević, S., Brkljačić, J. M., Teofilović, A., Elaković, I., Djordjevic, A. D., & Matić, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137206 · Cited by 5
Endocrine Disorders that Cause Diabetes
Jennings, R. E., & Hanley, N. A. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch20 · Cited by 5
Glucocorticoids reduce Slc2a2 ( GLUT2 ) gene expression through HNF1 in pancreatic β-cells
Ono, Y., & Kataoka, K. (2024) · Journal of Molecular Endocrinology · doi:10.1530/jme-24-0077 · Cited by 4
Pofi, R., Othonos, N., Marjot, T., Bonaventura, I., Barrett, A., White, S. J., Miller, H., Potter, T., Bailey, M., Eastell, R., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02637-x · Cited by 4
CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance
Contreras, P. H., & Falhammar, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1647028 · Cited by 4
Rose, M., Filiatreault, A., Williams, A., Guénette, J., & Thomson, E. M. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116526 · Cited by 7
Poredoš, P., Gh, S., Blinc, A., Mikhailidis, D. P., Jensterle, M., Anagnostis, P. G., Pl, A., Studen, K. B., Šabović, M., & Jezovnik, M. K. (2023) · Current Vascular Pharmacology · doi:10.2174/0115701611272145231106053914 · Cited by 4
Perez, J. A. (2024) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2024.03.003 · Cited by 4
New options in the treatment of Cushing’s disease: a focus on pasireotide
Chevalier, N., & Poullot (2013) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s30972 · Cited by 4
Miceli, D. D., Abiuso, A. M. B., Vidal, P. N., Gallelli, M. F., Pignataro, O. P., & Castillo, V. A. (2018) · Open Veterinary Journal · doi:10.4314/ovj.v8i1.13 · Cited by 4
Pituitary microadenomas — current diagnostic and treatment methods
Astafyeva, L. I., Кадашев, Б. А., Sidneva, Y., Chernov, I. V., & Kalinin, P. L. (2020) · Burdenko s Journal of Neurosurgery · doi:10.17116/neiro202084021110 · Cited by 4
Obesity-diabetes-endocrinopathy – the metabolic connection
Kozakowski, J., Dudek, P., & Zgliczyński, W. (2022) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2022.4.12 · Cited by 4
Ahdi, M., Gerards, M. C., Smits, P. H. M., Meesters, E. W., Brandjes, D. P. M., Nieuwdorp, M., & Gerdes, V. E. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1200183 · Cited by 4
del Bosque‐Plata, L., Amin, M., González‐Ramírez, R., Wu, R., Postolache, T. T., Vergare, M. J., Gordon, D., & Gragnoli, C. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01710-x · Cited by 4
Tsurutani, Y., Miyoshi, K., Inoue, K., Takiguchi, T., Saito, J., Omura, M., & Nishikawa, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0445 · Cited by 4
Morbidität und Mortalität beim Cushing-Syndrom
Vogel, F., Braun, L., & Reincke, M. (2021) · Der Internist · doi:10.1007/s00108-021-01222-7 · Cited by 1
Side effects of glucocorticoids: in vivo models and underlying mechanisms
Dodonova, S. A., Михайловна, Ж. Е., Kryukov, A. A., Valiev, T. T., Kulikov, E. P., Геннадиевна, Я. М., & Lesovaya, E. A. (2025) · Discover Medicine · doi:10.1007/s44337-025-00453-z · Cited by 4
Pasireotide for the treatment of Cushing's disease
Colao, A., Simeoli, C., de Leo, M., Cozzolino, A., & Pivonello, R. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.807731 · Cited by 2
Self-citationAcute Severe Cushing Syndrome: Not Always Ectopic Acth Syndrome
Bello, C., Gil, I., Serra, F. A., & Duarte, J. S. (2017) · AACE Clinical Case Reports · doi:10.4158/ep171905.cr · Cited by 3
Nandhini, L. P., Kamalanathan, S., & Sahoo, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_6 · Cited by 3
Pituitary Dysfunction as a Cause of Cardiovascular Disease
Gogakos, A. I., Gogakos, T., Kita, M. D., & Efstathiadou, Z. A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612824999201105165351 · Cited by 3
Wang, B., Yang, Y., Yuan, H., & Li, X. (2021) · International Journal of Endocrinology · doi:10.1155/2021/9536730 · Cited by 3
Obesity-Related Hemodynamic Alterations in Patients with Cushing’s Disease
Jurek, A., Krzesiński, P., Uziębło‐Życzkowska, B., Witek, P., Zieliński, G., Wierzbowski, R., Kazimierczak, A., Banak, M., & Gielerak, G. G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061658 · Cited by 3
Iglesias, P., Nobre, E. L., Hanzu, F. A., Schweizer, J. R. D. O. L., Valero, L. M., Araujo-Castro, M., Luna, A. C., Albacete, F. J., Villar‐Taibo, R., & Reinke, M. (2026) · Endocrine · doi:10.1007/s12020-026-04587-7 · Cited by 2
Bone mineral density in patients with Cushing’s syndrome
Seker, A., & Yavuz, D. G. (2024) · Marmara medical journal · doi:10.5472/marumj.1485351 · Cited by 2
Carbohydrate metabolism in patients with acromegaly and Itsenko—Cushing disease
Matchekhina, L. V., Belaya, Z. E., Mel'nichenko, G. A., & Shestakova, M. V. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh2015871098-104 · Cited by 2
Schranz, M., Lucà, M. G., D’Antiga, L., & FAGIUOLI, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-96400-3_22 · Cited by 2
Parkulo, T. D. (2014) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.265 · Cited by 2
Kamenova, T., Nankova, A., Kirova, I., Кirilov, G., Zacharieva, S., & Elenkova, A. P. (2025) · Cureus · doi:10.7759/cureus.92759 · Cited by 1
Iwata, H., Miyashita, C., Yamaguchi, T., Ikeda, A., Miura, R., Minatoya, M., Tamura, N., Bamai, Y. A., Itoh, S., Yamazaki, K., et al. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-02022-8 · Cited by 1
Di, D. G., Vicennati, V., Rinaldi, E., Morselli‐Labate, A. M., Giampalma, E., Mosconi, C., Pagotto, U., & Pasquali, R. (2012) · 15th International & 14th European Congress of Endocrinology · Cited by 1
Antevska, A., Long, C. C., Dupuy, S. D., Collier, J. J., Karlstad, M. D., & Do, T. D. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00668 · Cited by 2
Alkwatli, K., Kodali, A. M., & Pantalone, K. M. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.02.003 · Cited by 1
Diabetes Associated with Glucocorticoid Excess
Janssen, J. A. M. J. L., & Lamberts, S. W. J. (2014) · Frontiers in diabetes · doi:10.1159/000357244 · Cited by 1
Lirov, R., & Gauger, P. G. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_26 · Cited by 1
Physiopathology, Diagnosis, and Treatment of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2018) · Endocrinology · doi:10.1007/978-3-319-44444-4_12 · Cited by 1
Self-citationRationale to search for masked hypertension in severe Cushing's disease
Koracevic, G. P., STOJANOVIC, M. S., STOJANOVIC, S. S., Lović, D. B., & Djordjević, M. (2023) · Minerva Medica · doi:10.23736/s0026-4806.19.06327-4 · Cited by 1
Dunford, E. C. (2016) · YorkSpace (York University) · Cited by 1
Long-Term Complications of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64305-2 · Cited by 1
Self-citationEffets métaboliques des hypercorticismes exogènes
Fardet, L. (2013) · Obésité · doi:10.1007/s11690-013-0361-1
Physiopathology, Diagnosis, and Treatment of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2017) · Endocrinology · doi:10.1007/978-3-319-38681-2_12-1
Self-citationAdrenal Function and Skeletal Regulation
Chiodini, I., Battista, C., Cairoli, E., Eller-Vainicher, C., Morelli, V., Palmieri, S., Salcuni, A. S., & Scillitani, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-75110-8_7
High Resolution Mass Spectroscopy for Single Cell Analysis
Zhao, X. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.18.003196
Septar, A., Ilie, I., Tulin, A., Terzea, D., Hortopan, D., Goldstein, A., Chiriac, I., Ţupea, C., Oprea, L., Banica, A., et al. (2019) · Romanian Biotechnological Letters · doi:10.25083/rbl/24.4/736.741
Analysis of Clinical Characteristics of Glucose Metabolism in 118 Patients with Cushing’s Syndrome
怀, 宙. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.113142
Pituitary adenomas: current principles of diagnosis and treatment
Astafyeva, L. I., Chernov, I. V., Chekhonin, I. V., Shults, E. I., Pronin, I., & Kalinin, P. L. (2021) · Russian journal of neurosurgery · doi:10.17650/1683-3295-2020-22-4-94-111
Diabetes secondary to endocrine diseases
Institutul Naţional de Endocrinologie „C.I. Parhon“, B., Ghemigian, A. M., Universitatea de Medicină şi Farmacie „Carol Davila“, B., Popescu, I., Institutul Naţional de Endocrinologie „C.I. Parhon“, B., Petrova, E. N., Institutul Naţional de Endocrinologie „C.I. Parhon“, B., Buruiană, A., & Institutul Naţional de Endocrinologie „C.I. Parhon“, B. (2015) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2015.3.9
Cardiovascular risk in patients with Cushing’s disease – an interdisciplinary problem
Jurek, A., Krzesiński, P., Gielerak, G. G., Uziębło‐Życzkowska, B., Witek, P., Zieliński, G., Kazimierczak, A., & Wierzbowski, R. (2021) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2021.0045
Unilateral nodular adrenocortical hyperplasia presenting as Cushing’s syndrome: a case report
Naznin, L., Giti, S., Islam, S. M. J., Akhter, K. R., Yasmin, S., & Islam, M. (2021) · BIRDEM Medical Journal · doi:10.3329/birdem.v12i1.57231
Novel monitoring and management strategies for hepatic glycogen storage diseases
Rossi, A. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.202010693
Blount, S. L., & Silverstein, J. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_22
Nandhini, L. P., Kamalanathan, S., & Sahoo, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_6
Diabetes in Hypersecreting Endocrine Disorders
Vaag, A. A., Hanley, N. A., & Kistorp, C. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch22
Molecular biology, genetic, and epigenetics of adrenal tumor
Baghdadabad, L. Z., Ahadi, Z., Roudgari, H., & Ebrahimi, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-27302-5.00017-6
Cushing’s Syndrome and Diabetes
Peicher, K., & Meneghini, L. (2018) · American Diabetes Association eBooks · doi:10.2337/9781580406666.case45
Long-term complications of hypercortisolism
Pivonello, R., Crescenzo, E. M., Simeoli, C., Paola, N. D., Larocca, A., & Colao, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00123-0
Self-citationCosecreting Adrenal Tumor Causing Severe Insulin Resistance
Rivera, K., Cusi, K. J., & Edwards, C. (2015) · doi:10.2337/9781580405713.case35
(2018) · American Diabetes Association eBooks · doi:10.2337/9781580406666.partiii-iii
Ferrière, A., & Tabarin, A. (2025) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2025.07.002
Wang, M., Li, S., Cui, Q., Huang, B., & Cui, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1678472
Hyperglycémie induite par l’analogue de somatostatine pasiréotide au cours de la maladie de Cushing
Reznik, Y., Bisot-Locard, S., & Vergès, B. L. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30072-9
Rossi, A., Simeoli, C., Salerno, M., Ferrigno, R., Casa, R. D., Colao, A., Strisciuglio, P., Parenti, G., Pivonello, R., & Melis, D. (2020) · Figshare · doi:10.6084/m9.figshare.12153864
Self-citationRossi, A., Simeoli, C., Salerno, M., Ferrigno, R., Casa, R. D., Colao, A., Strisciuglio, P., Parenti, G., Pivonello, R., & Melis, D. (2020) · Figshare · doi:10.6084/m9.figshare.12153858
Self-citationCushing´s syndrome: Clinical presentation and associated comorbidities
Abreu-Lomba, A., Salazar-Solarte, A. M., Trujillo, D. A. V., & Martínez, W. A. R. (2026) · Vitamins and hormones · doi:10.1016/bs.vh.2026.04.001
Zhang, D., Su, W., Liu, J., Liu, S., Wei, Y., You, H., Hou, B., Mao, X., Zhang, Y., Deng, K., et al. (2026) · Endocrine · doi:10.1007/s12020-026-04748-8
Hypercortisolism: An Under‐Recognised Pathway Linked to Multi‐System Complications
Sacoto, H. D., & Fonseca, V. A. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71149
Bonaventura, I., Weigand, I., Isidori, A. M., Kroiß, M., & Reincke, M. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag035
Misiura, K. V., Seliukova, N. Y., Khoroshun, E. M., Nehoduiko, V. V., Макаров, Д., & Medvedovska, N. V. (2026) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2026.3.03
Metadata
- Authors
- Pivonello, R., De Leo, M., Vitale, P., Cozzolino, A., Simeoli, C., De Martino, M. C., Lombardi, G., & Colao, A.
- Affiliations
- Federico II University Hospital (IT)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2010
- Volume
- 92
- Issue
- Suppl. 1
- Pages
- 77-81
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2100232797
- Cited by
- 190
- References
- 24
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 14 · 2023: 13 · 2022: 8 · 2021: 15 · 2020: 14 · 2019: 13 · 2018: 13 · 2017: 11 · 2016: 10 · 2015: 17 · 2014: 13 · 2013: 16 · 2012: 14
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's syndrome, diabetes mellitus, glucocorticoid excess, insulin resistance, insulin secretion, gluconeogenesis, glucose tolerance, visceral adipose tissue, metabolic syndrome, pancreatic beta cells, lipolysis
- MeSH terms
- Insulin Secretion, Cushing Syndrome, Diabetes Mellitus, Glucose, Humans, Insulin, Insulin Resistance, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
